biospecimen__admin__batch_number	231.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	617C381D-127F-4F2A-BE0B-281A2D58B69C
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A3A7-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A3A7-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A3A7-01A
biospecimen__bio__biospecimen_barcode_bottom	0118957398
biospecimen__bio__day_of_creation	30
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	09
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-A3A7.B520F88D-4004-4DFA-BF8D-7CE96777C5A3.pdf
biospecimen__bio__plate_column	7
biospecimen__bio__plate_id	A22J
biospecimen__bio__plate_row	D
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A3A7
biospecimen__shared__patient_id	A3A7
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	05921F00-EDEE-4CDB-8D5F-CFB3A25E3D55
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.8
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.4
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	120
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Other
clinical__chol_lihc_shared__hist_hepato_carcinoma_risk	tobacco
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.4
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	12.0
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	10.6
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.1
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	67
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A3A7-F42004
clinical__clin_shared__bcr_followup_uuid	E21AE0B6-1747-43F4-86F6-8426E00ED875
clinical__clin_shared__cancer_first_degree_relative	4
clinical__clin_shared__day_of_form_completion	9
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	562
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	HBV Core Antibody
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	1998
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	144
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-DD-A3A7-D42005
clinical__rx__bcr_drug_uuid	30C072AE-2E51-4A99-82A1-9F7734A11DC5
clinical__rx__clinical_trail_drug_classification	Phase II
clinical__rx__days_to_drug_therapy_end	192
clinical__rx__days_to_drug_therapy_start	146
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3b
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	cf9a219b-5032-470b-95af-805dc325b20d
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A3A7-01A-11R-A22J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	bb6018d5-3781-424d-b7fe-1439ceed268f
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.84
gdc__analytes__analyte_id	6d37eff2-612a-4a5b-8622-a940f77b3994
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	614c0ecf-6a84-4c86-8706-79be5bb00991
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:54:50.037061-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	5ae53073-0b92-553a-a768-b7d287731aac
gdc__demographic__ethnicity	not reported
gdc__demographic__gender	male
gdc__demographic__race	not reported
gdc__demographic__year_of_birth	1931
gdc__demographic__year_of_death	1999
gdc__diagnoses__age_at_diagnosis	24599
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24599.0
gdc__diagnoses__days_to_death	419.0
gdc__diagnoses__diagnosis_id	31ce6fd1-8644-52d6-917f-f5275e33388c
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiib
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	22.634676324128563
gdc__exposures__exposure_id	38968395-e3dd-542a-a8cb-684b33f69176
gdc__exposures__height	188.0
gdc__exposures__weight	80.0
gdc__file_id	84cbd954-2d1c-44d0-aeac-fd0e3a22dbad
gdc__file_name	5b3c1508-dd1c-4b54-95f1-c37f540de214.mirbase21.mirnas.quantification.txt
gdc__file_size	50221
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	db5fe1a1d0e213d46003a211a8843779
gdc__portions__is_ffpe	false
gdc__portions__portion_id	80cd4c49-4d3e-4d02-a014-e2981128d174
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	4772
gdc__samples__initial_weight	130.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	B520F88D-4004-4DFA-BF8D-7CE96777C5A3
gdc__samples__sample_id	1ef290a3-d054-4e3a-9683-8f99a2010e3e
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	96.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	ce69a49a-d293-4aac-8c3f-bb9ba41c8087
gdc__submitter_id	mirna_swap_dr11_410_MirnaExpressionac666d33-6b28-4087-8bde-5ff9b218205d_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	dfe42dec-89d9-5ca9-adba-b4ecf333432b
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:13.439+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/cf9a219b-5032-470b-95af-805dc325b20d-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/cf9a219b-5032-470b-95af-805dc325b20d-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129592
manually_curated__local_md5	86c2cc6c346166e2aeaebe47f5ebfa55
manually_curated__opengdc_download_date	2018-10-16T17:10:58.000890+02:00
manually_curated__opengdc_file_md5	b2aa294874bf52b18b87430e18663904
manually_curated__opengdc_file_size	50220
manually_curated__opengdc_id	cf9a219b-5032-470b-95af-805dc325b20d-meq
manually_curated__origin_file_size	129592
manually_curated__origin_last_modified_date	Tue Oct 16 17:52:00 CEST 2018
manually_curated__origin_md5	86c2cc6c346166e2aeaebe47f5ebfa55
manually_curated__tissue_status	tumoral
